Cargando…

SAMHD1 as a prognostic and predictive biomarker in stage II colorectal cancer: A multicenter cohort study

BACKGROUND: The identification of high-risk population patients is key to the personalized treatment options for the stage II colorectal cancers. The use of proteomics in the prognosis of patients with stage II colorectal cancer remains unclear. METHODS: Using quantitative proteomics, we analyzed pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	You, Dingyun, Zhang, Shuai, Yan, Shan, Ding, Yingying, Li, Chunxia, Cheng, Xianshuo, Wu, Lin, Wang, Weizhou, Zhang, Tao, Li, Zhenhui, He, Yongwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376296/ https://www.ncbi.nlm.nih.gov/pubmed/35978833 http://dx.doi.org/10.3389/fonc.2022.939982

Ejemplares similares

Association Between Serum Carcinoembryonic Antigen Levels at Different Perioperative Time Points and Colorectal Cancer Outcomes
por: Li, Zhenhui, et al.
Publicado: (2021)

Trajectories of perioperative serum carcinoembryonic antigen and colorectal cancer outcome: A retrospective, multicenter longitudinal cohort study
por: Li, Zhenhui, et al.
Publicado: (2021)

Preoperative serum CA19-9 should be routinely measured in the colorectal patients with preoperative normal serum CEA: a multicenter retrospective cohort study
por: Li, Zhenhui, et al.
Publicado: (2022)

Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study
por: Li, Chunxia, et al.
Publicado: (2021)

Predictive Value of Postoperative Peripheral CD4+ T Cells Percentage in Stage I–III Colorectal Cancer: A Retrospective Multicenter Cohort Study of 1028 Subjects
por: Li, Zhenhui, et al.
Publicado: (2020)

Preoperative splenic area as a prognostic biomarker of early-stage non-small cell lung cancer
por: Liu, Mengmei, et al.
Publicado: (2023)

Implications of Habitual Alcohol Intake With the Prognostic Significance of Mean Corpuscular Volume in Stage II-III Colorectal Cancer
por: Liu, Qi, et al.
Publicado: (2021)

SAMHD1 Mutations and Expression in Mantle Cell Lymphoma Patients
por: Wang, Tao, et al.
Publicado: (2021)

Clinical Significances of Positive Postoperative Serum CEA and Post-preoperative CEA Increment in Stage II and III Colorectal Cancer: A Multicenter Retrospective Study
por: You, Weiqiang, et al.
Publicado: (2020)

Prognostic scoring system based on eosinophil- and basophil-related markers for predicting the prognosis of patients with stage II and stage III colorectal cancer: a retrospective cohort study
por: Gao, Lijing, et al.
Publicado: (2023)

Early Postoperative Serum Carcinoembryonic Antigen Is a Stronger Independent Prognostic Factor for Stage II Colorectal Cancer Patients Than T4 Stage and Preoperative CEA
por: Fenqi, Du, et al.
Publicado: (2022)

Prediction models of colorectal cancer prognosis incorporating perioperative longitudinal serum tumor markers: a retrospective longitudinal cohort study
por: Li, Chunxia, et al.
Publicado: (2023)

Vitamin D Status and Survival in Stage II-III Colorectal Cancer
por: Bao, Yichao, et al.
Publicado: (2020)

Clinicopathological Features Combined With Immune Infiltration Could Well Distinguish Outcomes in Stage II and Stage III Colorectal Cancer: A Retrospective Study
por: Ren, Jiazi, et al.
Publicado: (2021)

Evaluation of Traditional Prognostic Factors for Stage I-III Colorectal Cancer Patients Who Survived for Over Five Years After Surgery
por: Luo, Dakui, et al.
Publicado: (2021)

Expression Patterns of Microenvironmental Factors and Tenascin-C at the Invasive Front of Stage II and III Colorectal Cancer: Novel Tumor Prognostic Markers
por: Hashimoto, Mai, et al.
Publicado: (2021)

Prognostic and Predictive Models for Left- and Right- Colorectal Cancer Patients: A Bioinformatics Analysis Based on Ferroptosis-Related Genes
por: Chen, Yingying, et al.
Publicado: (2022)

Maspin as a Prognostic Marker for Early Stage Colorectal Cancer With Microsatellite Instability
por: Tanaka, Atsushi, et al.
Publicado: (2020)

A Novel Prognostic Model Incorporating Carcinoembryonic Antigen in 3-Week or Longer Postoperative Period for Stage III Colon Cancer: A Multicenter Retrospective Study
por: Fan, Jin, et al.
Publicado: (2020)

Successful Treatment of pMMR MSS IVB Colorectal Cancer Using Anti-VEGF and Anti-PD-1 Therapy in Combination of Gut Microbiota Transplantation: A Case Report
por: Cheng, Xianshuo, et al.
Publicado: (2023)

Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer—A Multicenter Study
por: Elicin, Olgun, et al.
Publicado: (2019)

Comparison of surgical resection and radiofrequency ablation for stages I and II elderly hepatocellular carcinoma patients (≥ 65 years): A SEER population-based propensity score matching’s study
por: Xie, Qingqing, et al.
Publicado: (2022)

Tumor microbiome analysis provides prognostic value for patients with stage III colorectal cancer
por: Kim, Jae Hyun, et al.
Publicado: (2023)

Higher Levels of Pre-operative Peripheral Lymphocyte Count Is a Favorable Prognostic Factor for Patients With Stage I and II Rectal Cancer
por: Zhang, Ying-Ying, et al.
Publicado: (2019)

Oncological Safety of Diagnostic Hysteroscopy for Apparent Early-Stage Type II Endometrial Cancer: A Multicenter Retrospective Cohort Study
por: Zhou, Hui, et al.
Publicado: (2022)

Adding Concurrent Chemotherapy to Intensity-Modulated Radiotherapy Does Not Improve Treatment Outcomes for Stage II Nasopharyngeal Carcinoma: A Phase 2 Multicenter Clinical Trial
por: Huang, Xiaodong, et al.
Publicado: (2020)

Prognostic risk analysis related to radioresistance genes in colorectal cancer
por: Qin, Haoren, et al.
Publicado: (2023)

Prognostic Value of Lymph Node Evaluation in Stage II Small Bowel Adenocarcinoma: An Updated Analysis of Surveillance, Epidemiology, and End Results Database
por: Liu, Zhen, et al.
Publicado: (2022)

Substrates and Inhibitors of SAMHD1
por: Hollenbaugh, Joseph A., et al.
Publicado: (2017)

The Prognostic Impact of the Metastatic Lymph Nodes Ratio in Colorectal Cancer
por: Zhang, Chi-Hao, et al.
Publicado: (2018)

Circulating Glycan Monosaccharide Composite-Based Biomarker Diagnoses Colorectal Cancer at Early Stages and Predicts Prognosis
por: Li, Haoran, et al.
Publicado: (2022)

Stage-dependent prognostic shift in mismatch repair-deficient tumors: Assessing patient outcomes in stage II and III colon cancer
por: Hestetun, Kjersti Elvestad, et al.
Publicado: (2022)

CT-Based Radiomics Signature: A Potential Biomarker for Predicting Postoperative Recurrence Risk in Stage II Colorectal Cancer
por: Fan, Shuxuan, et al.
Publicado: (2021)

High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer
por: Mohamed, Amr, et al.
Publicado: (2021)

Prognostic Factors and Optimal Response Interval for Stereotactic Body Radiotherapy in Patients With Lung Oligometastases or Oligoprogression From Colorectal Cancer
por: Li, Shuai, et al.
Publicado: (2019)

LINC00957 Acted as Prognostic Marker Was Associated With Fluorouracil Resistance in Human Colorectal Cancer
por: Zhang, Li Hua, et al.
Publicado: (2019)

Potential Metabolite Biomarkers for Early Detection of Stage-I Pancreatic Ductal Adenocarcinoma
por: Cao, Yingying, et al.
Publicado: (2022)

Expression of SAMHD1 and its mutation on prognosis of colon cancer
por: Zhang, Zhou, et al.
Publicado: (2022)

Immune Activation Influences SAMHD1 Expression and Vpx-mediated SAMHD1 Degradation during Chronic HIV-1 Infection
por: Fu, Weihui, et al.
Publicado: (2016)

Pretreatment Contrast-Enhanced Computed Tomography Radiomics for Prediction of Pathological Regression Following Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer: A Preliminary Multicenter Study
por: Xie, Kun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ujvbondlkvod7khf0f05nuc9dn